Loading ....
The product CSB-E05125h is a ready-to-use microwell, strip plate ELISA kit for quantitatively analyzing the presence of TNFSF11 in different biological samples, including serum, plasma, and tissue homogenates. This TNFSF11 ELISA kit specifically recognizes the human TNFSF11 in the sample. It adopts the Sandwich ELISA technique in conjunction with antibody-antigen specific binding and an enzyme colorimetric reaction to indicate the presence of human TNFSF11 and quantitatively measure the concentration of TNFSF11 in the samples.
rnrn
rnrnTNFSF11, also known as RANKL, is an osteoclastogenic cytokine that combines bone with the immune system. RANKL/RANK signaling regulates osteoclast development, bone metabolism, lymph node...
The product CSB-E05125h is a ready-to-use microwell, strip plate ELISA kit for quantitatively analyzing the presence of TNFSF11 in different biological samples, including serum, plasma, and tissue homogenates. This TNFSF11 ELISA kit specifically recognizes the human TNFSF11 in the sample. It adopts the Sandwich ELISA technique in conjunction with antibody-antigen specific binding and an enzyme colorimetric reaction to indicate the presence of human TNFSF11 and quantitatively measure the concentration of TNFSF11 in the samples.
rnrn
rnrnTNFSF11, also known as RANKL, is an osteoclastogenic cytokine that combines bone with the immune system. RANKL/RANK signaling regulates osteoclast development, bone metabolism, lymph node development, and T cell/dendritic cell communication. In addition to modulating bone resorption and remodeling, the RANKL/RANK axis is also involved in many other cellular processes, including immunity, proliferation and division of mammary epithelial cells, and mammary gland formation during lactation. Studies have shown that RANKL/RANK is involved in each stage of cancer development, from pre-cancerous lesions to the establishment of metastases.
Contact us to order
Tel
+1 866.986.9598
CUSABIO TECHONOLOGY LLC
view supplier detailsCredit card payments now incur a 3% fee.
rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rn rnrn 
